The CMTA-STAR Initiative

STAR, the CMTA’s research initiative, was created with one goal: to find treatments to slow, stop or reverse the progression of CMT. Working with investigators and scientists chosen from an international body of the world’s most accomplished medical pioneers, the CMTA-STAR is leading CMT research. The CMTA-STAR program’s success is due to the willingness of scientists working in their areas of expertise to come together as a team to advance CMT research, sharing and communicating ideas, discoveries and findings. The CMTA also works with the pharmaceutical, biotechnology and research service industries, non-profit research organizations and the National Institutes of Health. These relationships are a critical part of the CMTA-STAR initiative’s goal of rapidly delivering therapies to CMT patients. The integrated team of top scientists and industry partners working together toward a common goal is what sets the CMTA-STAR program apart and what drives its remarkable success.